MiR-28-5p involved in LXR-ABCA1 pathway is increased in the plasma of unstable angina patients

Heart Lung and Circulation

Volumn 24, Issue 7, 2015, Pages 724-730

  Liu, Jia ^a   Liu, Ying ^a   Sun, Ya Nan ^a   Li, Si ^a   Liu, Xue Qing ^a   Li, Jie ^a   Li, Chun Mei ^a   Tian, Wei ^a   Zhou, Yun Tao ^a   Shang, Xiao Ming ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

ABCA1; Circulation; LXR ; MiR 28 5p; Unstable angina

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MICRORNA; MICRORNA 28 5P; UNCLASSIFIED DRUG; ABCA1 PROTEIN, HUMAN; MIRN28 MICRORNA, HUMAN; ORPHAN NUCLEAR RECEPTOR;

ABCA1 GENE; ABCG1 GENE; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CELL LINE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LIPOPROTEIN SYNTHESIS; LIVER CELL; LXR GENE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA SEQUENCE; RNA TRANSCRIPTION; RNA TRANSLATION; SENSITIVITY AND SPECIFICITY; THP 1 DERIVED MACROPHAGE; TRANSLATION INITIATION; UNSTABLE ANGINA PECTORIS; UPREGULATION; AGED; ANGINA, UNSTABLE; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; PROGNOSIS; SIGNAL TRANSDUCTION;

AGED; ANGINA, UNSTABLE; ATP BINDING CASSETTE TRANSPORTER 1; BIOMARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; HEP G2 CELLS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; ORPHAN NUCLEAR RECEPTORS; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84930863833     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.12.160     Document Type: Article

References (46)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Dangwal S., Bang C., Thum T. Novel techniques and targets in cardiovascular microRNA research. Cardiovasc Res 2012, 93:545-554.
3. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006, 38:228-233.
4. Yang B., Lin H., Xiao J., Lu Y., Luo X., Li B., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13:486-491.
5. Liu N., Bezprozvannaya S., Williams A.H., Qi X., Richardson J.A., Bassel-Duby R., et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 2008, 22:3242-3254.
6. Limana F., Esposito G., D'Arcangelo D., Di Carlo A., Romani S., Melillo G., et al. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PloS One 2011, 6:e19845.
7. Wilson K.D., Hu S., Venkatasubrahmanyam S., Fu J.-D., Sun N., Abilez O.J., et al. Dynamic microrna expression programs during cardiac differentiation of human embryonic stem cells role for mir-499. Circ Cardiovasc Genet 2010, 3:426-435.
8. Adachi T., Nakanishi M., Otsuka Y., Nishimura K., Hirokawa G., Goto Y., et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 2010, 56:1183-1185.
9. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107:677-684.
10. Olivieri F., Antonicelli R., Lorenzi M., D'Alessandra Y., Lazzarini R., Santini G., et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol 2013, 167:531-536.
11. Kuwabara Y., Ono K., Horie T., Nishi H., Nagao K., Kinoshita M., et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 2011, 4:446-454.
12. Gupta S.K., Bang C., Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet 2010, 3:484-488.
13. Wang G.-K., Zhu J.-Q., Zhang J.-T., Li Q., Li Y., He J., et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010, 31:659-666.
14. Fichtlscherer S., Zeiher A.M., Dimmeler S. Circulating MicroRNAs Biomarkers or Mediators of Cardiovascular Diseases?. Arterioscler Thromb Vasc Biol 2011, 31:2383-2390.
15. Oerlemans M.I., Mosterd A., Dekker M.S., de Vrey E.A., van Mil A., Pasterkamp G., et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 2012, 4:1176-1185.
16. Girardot M., Pecquet C., Boukour S., Knoops L., Ferrant A., Vainchenker W., et al. miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood 2010, 116:437-445.
17. Almeida M.I., Nicoloso M.S., Zeng L., Ivan C., Spizzo R., Gafà R., et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012, 142:886-896.
18. Yang M., Yao Y., Eades G., Zhang Y., Zhou Q. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res Treat 2011, 129:983-991.
19. Wilting S.M., Snijders P.J.F., Verlaat W., Jaspers A., van de Wiel M.A., van Wieringen W.N., et al. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2013, 32:106-116.
20. Hooper C.L., Dash P.R., Boateng S.Y. Lipoma preferred partner is a mechanosensitive protein regulated by nitric oxide in the heart. FEBS Open Bio 2012, 2:135-144.
21. Jin L., Hastings N.E., Blackman B.R., Somlyo A.V. Mechanical properties of the extracellular matrix alter expression of smooth muscle protein LPP and its partner palladin; relationship to early atherosclerosis and vascular injury. J Muscle Res Cell Motil 2009, 30:41-55.
22. Gorenne I., Jin L., Yoshida T., Sanders J.M., Sarembock I.J., Owens G.K., et al. LPP Expression During In Vitro Smooth Muscle Differentiation and Stent-Induced Vascular Injury. Circ Res 2006, 98:378-385.
23. Najafi-Shoushtari S.H., Kristo F., Li Y., Shioda T., Cohen D.E., Gerszten R.E., et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328:1566-1569.
24. Rayner K.J., Suárez Y., Dávalos A., Parathath S., Fitzgerald M.L., Tamehiro N., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
25. Dávalos A., Goedeke L., Smibert P., Ramírez C.M., Warrier N.P., Andreo U., et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A 2011, 108:9232-9237.
26. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey D.E., et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2007, 50:e1-e157.
27. Mestdagh P., Van Vlierberghe P., De Weer A., Muth D., Westermann F., Speleman F., et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009, 10:R64.
28. Daigneault M., Preston J.A., Marriott H.M., Whyte M.K.B., Dockrell D.H. The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages. PloS One 2010, 5:e8668.
29. Turchinovich A., Samatov T.R., Tonevitsky A.G., Burwinkel B. Circulating miRNAs: cell-cell communication function?. Front Genet 2013, 4:119.
30. Tall A.R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N. HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis. Cell Metab 2008, 7:365-375.
31. Rayner K.J., Sheedy F.J., Esau C.C., Hussain F.N., Temel R.E., Parathath S., et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 2011, 121:2921-2931.
32. Ramírez C.M., Rotllan N., Vlassov A.V., Dávalos A., Li M., Goedeke L., et al. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ Res 2013, 112:1592-1601.
33. Ramirez C.M., Dávalos A., Goedeke L., Salerno A.G., Warrier N., Cirera-Salinas D., et al. MicroRNA-758 Regulates Cholesterol Efflux Through Posttranscriptional Repression of ATP-Binding Cassette Transporter A1. Arterioscler Thromb Vasc Biol 2011, 31:2707-2714.
34. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379.
35. Saraiya A.A., Li W., Wang C.C. Transition of a microRNA from Repressing to Activating Translation Depending on the Extent of Base Pairing with the Target. PloS One 2013, 8:e55672.
36. Vasudevan S., Tong Y., Steitz J.A. Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation. Science 2007, 318:1931-1934.
37. Ørom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a Binds the 5'-UTR of Ribosomal Protein mRNAs and Enhances Their Translation. Mol Cell 2008, 30:460-471.
38. Park S.-Y., Lee J.H., Ha M., Nam J.-W., Kim V.N. miR-29 miRNAs activate p53 by targeting p85α and CDC42. Nat Struct Mol Biol 2009, 16:23-29.
39. Song H., Wang Q., Wen J., Liu S., Gao X., Cheng J., et al. ACVR1, a Therapeutic Target of Fibrodysplasia Ossificans Progressiva, Is Negatively Regulated by miR-148a. Int J Mol Sci 2012, 13:2063-2077.
40. Cai J., Guan H., Fang L., Yang Y., Zhu X., Yuan J., et al. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. J Clin Invest 2013, 123:566.
41. Vasudevan S., Tong Y., Steitz J.A. Cell-cycle control of microRNA-mediated translation regulation. Cell Cycle 2008, 7:1545-1549.
42. Mortensen R.D., Serra M., Steitz J.A., Vasudevan S. Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs). Proc Natl Acad Sci U S A 2011, 108:8281-8286.
43. Schwindt H., Akasaka T., Zühlke-Jenisch R., Hans V., Schaller C., Klapper W., et al. Chromosomal Translocations Fusing the BCL6 Gene to Different Partner Loci Are Recurrent in Primary Central Nervous System Lymphoma and May Be Associated With Aberrant Somatic Hypermutation or Defective Class Switch Recombination. J. Neuropathol. Exp. Eeurol. 2006, 65:776-782.
44. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nuclear Acids Res 2003, 31. e15-e15.
45. Huber W., Von Heydebreck A., Sültmann H., Poustka A., Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002, 18:S96-S104.
46. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80.